AbstractThe diploma thesis at hand examines the impact the new, tightened anti-corruption provisions have on the medical field. In the process, the question of where the boundary between acceptable as well as necessary cooperation and punishable corruption lies concerning the cooperation of doctors and the medical industry shall be clarified. In the first chapter, the new, tightened corruption provisions affecting both the private and public sectors -established by the Criminal Law Amendment Act of 2008- are discussed. Subsequently, the second chapter highlights those amendments which became effective as a result of the Anti-Corruption Criminal Law Amendment Act of 2009 and led to a specification of the ambiguous definitions as well as the differentiation of criminal acts based on the degree of their unlawfulness. The main section of this paper is presented in the third chapter, where it is discussed if a doctor falls within the scope of application of the anti-corruption provisions in the private or public sector and where the line is drawn between conduct that is punishable and conduct that is not subject to legal punishment. The second part of the third chapter deals with the most important codes of conduct of certain special interest groups which are supposed to protect their members from the risk of committing a punishable act of corruption. Finally, the standards and sanctioning mechanisms at the sub-constitutional level are discussed, which regulate the cooperation of medical or pharmaceutical professionals and the industry.